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Abstract
At Gesellschaft für Schwerionenforschung (GSI) more than 330 patients have been treated with
scanned carbon ion beams in a pilot project. To date, only stationary tumors have been treated. In
the presence of motion, scanned ion beam therapy is not yet possible because of interplay effects
between scanned beam and target motion which can cause severe mis-dosage. We have started a
project to treat tumors that are subject to respiratory motion. A prototype beam application
system for target tracking with the scanned pencil beam has been developed and commissioned.
To facilitate treatment planning for tumors that are subject to organ motion, we have extended
our standard treatment planning system TRiP to full 4D functionality. The 4D version of TRiP
allows to calculate dose distributions in the presence of motion. Furthermore, for motion
mitigation techniques tracking, gating, rescanning, and internal margins optimization of treatment
parameters has been implemented. 4D calculations are based on 4D computed tomography data,
deformable registration maps, organ motion traces, and beam scanning parameters.
We describe the methods of our 4D treatment planning approach and demonstrate functionality
of the system for phantom as well as patient data.
Background
Intrafractional target motion
Intrafractional target motion has a relevant impact on the
precision of treatment delivery in conformal radiother-
apy. Even if treatment planning margins are sufficient to
encompass the full extent of motion, intrafractional
motion degrades dose gradients to surrounding healthy
tissue [1,2]. For intensity modulated therapy like IMRT or
scanned particle therapy, the relative motion between tar-
get and multi-leaf collimator or scanned beam can have a
severe impact on the delivered dose. These interplay
effects between target and beam motion usually cause hot
and cold spots in the delivered dose distributions [1,3-
10].
To mitigate the impact of intrafractional motion, several
techniques were proposed but have not yet been used
clinically with scanned particle beams: beam gating
[11,12], rescanning [13,14], tracking [15-17], and internal
margins (IM) to generate an internal target volume (ITV)
[18]. Besides tracking, all other techniques require IMs
due to unmitigated or residual motion. For particle
beams, the use of ITVs requires explicit consideration of
possible range changes because ranges are most often
influenced by organ motion [19,20]. Adjustments of the
beam range, e.g. by compensator smearing, have to be
applied to ensure coverage of the distal field edge for all
motion states of the target [19,21].
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Precise motion mitigation techniques require quantifica-
tion of the motion, for example by time resolved com-
puted tomography (4DCT) [22-26] or 4D magnetic
resonance tomography (MRT) [27]. Both techniques sam-
ple periodical motion in several motion phases. The
motion phases correspond to quasi-static 3D volumes,
e.g. standard CT volumes. Usually sampling is based on
an external motion surrogate [28-30]).
Several investigators have used time-resolved volumetric
imaging to extend treatment planning capabilities for
tumor sites influenced by respiratory motion [21,31-34].
The main idea was reported by Keall et al. [32] and Rietzel
et al. [33]: Dose calculations are performed per motion
phase of 4DCT data. Deformation maps obtained by non-
rigidly registering motion phases are then used to trans-
form the resulting sub-dose distributions to a reference
motion phase for effective dose calculation by time
weighted summation.
Carbon ion therapy at GSI
At Gesellschaft für Schwerionenforschung (GSI) charged
particle therapy is performed with an intensity-modu-
lated, raster-scanned carbon ion beam in collaboration
with the University Hospital Heidelberg, the German
Cancer Research Center, and the Forschungszentrum Ros-
sendorf. To date, more than 330 patients with tumors in
the head, neck, spinal cord, and pelvis region have been
stereotactically treated within the pilot project [35,36].
GSI plans to treat tumors affected by respiratory motion
by tracking. Consequently we have started a project to
develop beam application and treatment planning capa-
bilities for this technique [15,37,38]. For a short introduc-
tion, the following paragraphs summarize standard
treatment delivery and treatment planning for scanned
carbon ion beams as well as the current status of the track-
ing project.
Treatment delivery is performed with the active raster-
scanner system [39]. In beam's eye view, the planning tar-
get volume (PTV) is divided into j slices of iso-energies Ej
(typical slice distance: 3 mm water-equivalent). Each iso-
energy slice contains a regular grid (typical grid spacing:
2–3 mm) of i beam positions (xi, yi). Individual pencil
beams with a focus of 3–9 mm (full width at half maxi-
mum) are applied per grid position. To achieve the
desired dose distribution, the number of carbon ions Nij is
optimized for each position. During treatments, a syn-
chrotron accelerates carbon ion pencil beams to the
required beam energy Ej. Particle extraction from the syn-
chrotron is performed in beam pulses with a length of 2.2
s followed by 3.3 s of acceleration for the next energy. For
each iso-energy slice (IES) a new pulse has to be requested
from the synchrotron because beam energy can – up to
now – not be changed within a pulse. For each IES the
pencil beam is scanned by a magnetic deflection system
across all beam positions with Nij > 0. The scanning proc-
ess is controlled by fluence monitors. They measure the
number of particles deposited per beam position and
request transition to the next position as soon as the
required number of particles Nij has been reached. The
beam is not turned off during transition to the next grid
position. Scanning speed (up to 11m/s) is thus dependent
on Nij and the synchrotron extraction profile.
Treatment planning is performed with the GSI treatment
planning system TReatment planning for Particles (TRiP)
based on a native computed tomogram (CT) and a set of
contours [40,41]. Dose calculation is performed with a
pencil beam algorithm. For calculation of dose D at each
CT voxel center (x, y, z) the contributions from all beam
positions are summed:
d(Ej, z) quantifies the energy loss distribution for a certain
beam energy Ej with respect to traversed amount of tissue
z  in water-equivalent units. During optimization, the
energy levels Ej and the raster grid (xi, yi) are set to cover
the extent of the PTV in beams-eye-view. The minimal
beam-width is determined by the grid-spacing (uniform
in x and y) according to σ > 1.27 (xi + 1 - xi). To calculate
the longitudinal extent (zmin - zmax) of the target, CT num-
bers are converted into particle ranges based on a Houns-
field look-up table [42]. Optimization of Nij is performed
by least square minimization such that D(x, y, z) meets the
prescribed dose.
For tracking, beam parameters (x, y, z) have to be adjusted
at the time of irradiation to compensate motion of the tar-
get (see fig. 1). A prototype system has been built which
allows lateral and longitudinal adaptation of the beam
(see fig. 2) [37]. In beam's eye view, adaptation of the lat-
eral beam position (∆x, ∆y) is performed by changing the
target positions of the raster-scanner system during deliv-
ery. Changes in particle range ∆z have to be compensated
with a passive energy modulation system because syn-
chrotron settings can not yet be adapted within an extrac-
tion pulse. In our current prototype system a pair of lucite
wedges mounted on linear motors is used [43].
4D treatment planning for scanned ion beams
The combination of scanned particle beams and target
motion represents a double-dynamic system that requires
a dedicated solution for 4D treatment planning. We
extended our treatment planning system TRiP [40] to full
4D functionality to allow dose calculation and parameter
optimization in the presence of motion. In principle the
4D functionality can handle all types of motion. In the
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following we will, however, focus on respiratory motion
as this is our initial intended application.
In order to compare different motion mitigation tech-
niques like tracking, gating, rescanning, and internal mar-
gins, the 4D version of TRiP allows to
i. generate particle specific ITVs for treatment plan optimi-
zation of gating and rescanning,
ii. optimize parameters for motion compensation (track-
ing),
iii. calculate physical dose distributions in the presence of
motion as well as for tracking, gating, rescannning, and
the use of internal margins.
In contrast to previous simulation studies of our group
[15,17], we have implemented 4D treatment planning
based on multiple volumetric data sets, e.g. CT data sets.
In addition, ITV generation and optimization of tracking
parameters including methods to correct for target rota-
tion and deformation were realized. Calculation of physi-
cal dose distributions can be performed for patient data
with patient specific, non-rigid motion.
The purpose of this contribution is the technical descrip-
tion of the 4D treatment planning extensions. The func-
tionality will be presented for phantom simulations as
well as for an example patient data set. Experimental vali-
dation and application to clinical data of lung cancer
patients will be reported elsewhere.
Dose calculations in the presence of target 
motion
For scanned particle beams, 4D dose calculations require
temporal correlation of beam motion and organ motion
considering possible changes in particle range. Dose cal-
culations are based on a reference motion phase inde-
pendent of the motion mitigation technique (see fig. 1).
The following sections describe the calculation of dose
distributions in the presence of motion as well as the
parameters that are required for these calculations.
Organ motion parameters
For treatment planning we assume organ motion to be
non-rigid as well as represented by time-resolved volu-
metric data that allows precise calculation of particle
ranges, e.g. CT data. For respiratory motion measured by
4DCT, motion is assumed to be periodical. Temporally,
organ motion has to be measured in correlation to beam
motion (section Beam motion parameters). Spatially,
organ motion is described with respect to the particle
beam and with respect to a reference motion phase (fig.
1).
Schematic outline of the prototype compensation system  developed at GSI Figure 2
Schematic outline of the prototype compensation 
system developed at GSI. For each iso-energy slice, car-
bon ions are accelerated in a synchrotron to the required 
energy E. Laterally, the pencil beam is scanned by magnetic 
deflection. Lateral compensation is performed by adapting 
the nominal magnet settings. Longitudinal compensation has 
to be performed with a pair of plastic wedges mounted on 
linear motors because the beam energy can currently not be 
changed during an extraction cycle. Particle ranges are 
adapted by varying the thickness of the traversed plastic in 
the beam. (image according to [37])
Schematic drawing of 3D tumor motion in the coordinate  system of the scanned ion beam Figure 1
Schematic drawing of 3D tumor motion in the coor-
dinate system of the scanned ion beam. The tumor is 
depicted in its reference position (grey) and in a second posi-
tion corresponding to a different motion phase (red). The 
scanning coordinate system consists of iso-energy layers (z in 
water-equivalent units) as well as grid positions within these 
layers (x, y). Motion of a grid position is indicated by a motion 
vector (white). ∆(x, y, z) are the parameters required for 
motion compensation.Radiation Oncology 2007, 2:24 http://www.ro-journal.com/content/2/1/24
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3D information of the motion like amplitude, trajectory,
and volumetric changes are included in the 4DCT phases.
Quantitatively, the motion is parametrized by B-splines
which describe the non-rigid motion components
between 4DCT phases. Optimization and application of
these transformation maps are performed with vtkCISG
[44]. Details on calculation and validation of the transfor-
mation data have been reported previously by Rietzel et
al. [33,45].
Temporal changes from 3D data set to 3D data set were
implemented via motion traces. For example 4DCT
period and initial respiratory phase can be given by a
motion trajectory. The 4D version of TRiP allows han-
dling of measured motion trajectories, modeling of sinu-
soidal motion, or modeling motion according to Lujan et
al. [46].
Beam motion parameters
With beam motion we refer to the time dependent move-
ment of the raster-scanned pencil beam as it traverses the
target volume grid-position by grid-position and slice-by-
slice (see fig. 2 and section Carbon ion therapy at GSI).
Pencil beam motion is quantitatively determined by the
particle intensity profile extracted from the synchrotron,
the number of particles per grid-position Nij, the order of
beam positions (xi, yi) within each iso-energy slice j, and
the order in which iso-energy slices are irradiated.
Particle extraction is not exactly deterministic or reproduc-
ible (see fig. 2 in [15]). Slight changes in the acceleration
and especially the extraction process lead to changes that
do not affect irradiations of stationary targets but cause
changes in the temporal progress of the scanning process.
For precise dose calculations in the presence of organ
motion, beam intensity and irradiation time of each indi-
vidual beam position (typical duration < 10 ms per posi-
tion) have to be considered in temporal correlation to
organ motion.
The 4D version of TRiP can handle measured intensity dis-
tributions and can model the extraction characteristics at
GSI as well as the characteristics of the Heidelberg Ion-
Therapy center (HIT, under construction) [47]. In contrast
to GSI's synchrotron with so called slow extraction,
knock-out-extraction [48] will be used at HIT. This extrac-
tion method allows intermitted extraction within one
pulse and thus optimal gated irradiations. Modeling of
the extraction pattern for gated irradiations has to be per-
formed for each motion trajectory and gating window
combination individually because the pulse structure
(~1.5s acceleration for each iso-energy slice followed by a
maximal pulse length of 10 s) is fixed. Treatment planning
can thus also be used to estimate realistic treatment times
for gated irradiations.
Generation of quasi-static sub-treatment plans
For all motion mitigation techniques, treatment delivery
is based on a reference motion phase. For respiratory
motion, this reference motion phase typically corre-
sponds to the end-exhale phase of the 4DCT data. Using
the standard functionality of TRiP [40], a reference treat-
ment plan (x,  y,  E,  N) is optimized on the reference
motion phase. This reference treatment plan is then
applied to the moving target by raster-scanning. The refer-
ence treatment plan is modified by compensation param-
eters  ∆(x,  y,  z,  N) at time of delivery for tracking,
interrupted for delivery by gating, applied multiple times
for rescanning, and unchanged for mitigation by internal
margins.
Independent of the motion mitigation technique, 4D
dose calculations have to temporally correlate the delivery
of each single pencil beam position with the motion of
the target as described by motion trajectory and 4DCT
(see fig. 3b). In analogy to 4DCT, the reference treatment
plan is split into sub-treatment plans by attributing each
individual grid position to a motion phase. This is per-
formed by processing motion characteristics simultane-
ously to beam extraction profiles. Then each sub-
treatment plan includes all beam positions (x, y, E, N) of
the reference treatment plan which are irradiated during
the corresponding motion phase (see fig. 3a). Within our
treatment planning code, splitting of treatment plans can
be based on motion amplitude or phase of the motion tra-
jectory. Ideally, it should be consistent with the method
used during 4DCT data acquisition. Then sub-treatment
plans and corresponding 4DCT phases can be used to cal-
culate sub-dose distributions. Each sub-dose distribution
Temporal correlation of scanning progress and organ motion Figure 3
Temporal correlation of scanning progress and organ 
motion. Dose calculation requires temporal correlation of 
scanning progress and organ motion. a) Based on a motion 
trajectory the actual motion phase is determined. In this 
example 10 motion phases were used. b) Scanning progress 
is determined by the extracted beam intensity and the 
number of particles per grid position Nij. Scanning progress, 
i.e. the delivery time of each grid position, is not linear 
because Nij can differ within iso-energy slices (left). Signal 
heights are plotted in arbitrary units.Radiation Oncology 2007, 2:24 http://www.ro-journal.com/content/2/1/24
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contains the cumulative dose delivered by the reference
treatment plan during that specific motion phase – over
all occurrences of that motion phase during the treatment.
In contrast to other motion mitigation techniques, track-
ing changes beam parameters. Corresponding sub-treat-
ment plans require consideration of compensation
parameters. Adjustment of lateral beam positions (∆x, ∆y)
and numbers of particles ∆N can readily be applied (e.g.
xnew = x + ∆x). The longitudinal change ∆z corresponds to
a shift of the depth dose distribution (d(E, z + ∆z)) and has
to be considered in the summation of dose contributions
(eq.1).
Effective dose distributions
Sub-dose distributions represent the cumulative dose
delivered within a specific motion phase. For evaluation
of a treatment scenario (e.g. mitigation technique, target
motion parameters, extraction rate), the effective dose dis-
tribution of the complete treatment plan has to be calcu-
lated. Because the quasi-static motion phases are not
anatomically registered the sub-dose distributions can not
simply be summed but need to be transformed to the ref-
erence motion phase. Transformation maps which quan-
titatively describe the non-rigid motion (see section
Organ motion parameters) are used to transform each
sub-dose distribution to the reference motion phase. The
transformed sub-dose distributions can then be summed
time weighted to calculate the effective dose distribution.
Dose calculation examples
To illustrate the steps of 4D dose calculation, we present
the irradiation of a simple phantom with tracking in fig.
4. The phantom is homogeneous except for the slab on
the left top with higher density. A 4DCT data set was con-
structed with the indicated target volume (white contour)
moving periodically. A treatment plan was optimized to
deposit a homogeneous dose distribution in the target on
the reference 4DCT phase (fig. 4a). In addition, a sinusoi-
dal motion trajectory was constructed. The temporal cor-
relation of target motion and scanned beam leads to sub-
treatment plans and quasi-static sub-dose distributions
for each motion phase. Fig. 4c, e show the sub-dose distri-
butions for peak motion phases comparable to end-inha-
lation and end-exhalation. Despite the motion the dose is
deposited in the target volume because tracking compen-
sates target motion including adaptation of particle ranges
(shift of d(E, z) visible in fig. 4c). Fig. 4d, f show the same
sub-dose distributions transformed to the reference
motion phase. The effective, summed dose distribution
on the reference motion phase is shown in fig. 4b. It is
comparable to the reference dose distribution calculated
for a stationary target in fig. 4a. The only differences occur
distal of the sharp CT gradient caused by the slab on the
left top. The width of the pencil beams (~7 mm full width
at half maximum) results in overshooting distal of the
sharp gradient for some parts of the diameter of the pencil
beams (this is an artificial situation which is unlikely to
occur in patient treatment). For motion tracking, this
effect is largely reduced, i.e. smeared out, because the
static CT gradient causes the described effect at different
positions in the moving target volume.
Optimization of treatment plans
Changes in the optimization of treatment plans for mov-
ing targets in comparison to the algorithms used for
standard irradiations (see section Carbon ion therapy at
GSI and [40]) depend on the motion mitigation tech-
nique. The following sections describe our implementa-
tions of rescanning, gating, internal margins, and tracking.
Optimization for rescanning, gating, and internal margins
In contrast to tracking, gating and rescanning do not
require change of treatment parameters during delivery.
However, particle specific ITVs have to be generated for
both techniques. Particle specific ITVs account for possi-
ble range changes due to organ motion [21]. ITVs ensure
target dose coverage in each 4DCT phase for rescanning or
for the subset of 4DCT phases included in the gating win-
dow.
Simulation of a phantom irradiation Figure 4
Simulation of a phantom irradiation. Simulation of a 
phantom irradiation to illustrate the steps of dose calculation 
in the presence of motion using tracking. 4DCT data were 
modelled static, with exception of the target (white contour) 
which moves up and down. Shown are overlays of relative 
dose distributions on the CT motion phases. a) Reference 
motion phase with reference dose distribution for the sta-
tionary target. b) The resulting dose distribution for tracking 
which is comparable to a). Small differences distal of the 
sharp CT gradient occur due to the finite pencil beam width 
(see text for details). The effective dose distribution is the 
weighted sum of transformed sub-dose distributions at all 
motion phases. Sub-dose distributions at extreme target 
positions are shown in c) and e) and transformed to the ref-
erence motion phase in d) and f).Radiation Oncology 2007, 2:24 http://www.ro-journal.com/content/2/1/24
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Timing of the beam delivery sequence is modified for gat-
ing, where the beam is turned on only within the gating
window, e.g. close to the end-exhale breathing phase. The
gating window has to be defined for the optimization.
Rescanning also changes timing of the beam delivery
sequence because the same irradiation pattern is applied
several times. The number of particles per grid position is
therefore divided by the number of rescans. Typically the
beam fluence is constant but the scanning speed increases.
Besides ITV generation, the definition of the number of
rescans is the main task for optimization of rescanning.
The procedure for ITV generation in our active beam deliv-
ery environment is as follows:
i. Required input: native 4DCT and ITV contour
ii. Calculation of the maximal lateral ITV extension in
beam's eye view (BEV) and setup of the raster grid (xi, yi)
iii. Definition of iso-energy slices (IES with accelerator
energies Ej): The IES are arranged from the distal to the
proximal water-equivalent extension of the ITV. Because
tumor motion influences particle ranges the extreme
water equivalent ranges of all 4DCT phases have to be
considered per grid position to ensure target dose cover-
age to the distal edge independent of the motion phase
during irradiation.
iv. Calculation of the water-equivalent depth for each CT
voxel as required for dose calculation (d(E, z) in eq.1):
Because the depth is influenced by organ motion the max-
imum depth from all 4DCT phases has to be used per
voxel.
v. Optimization of Nij at each grid position (xi, yi) based
on the maximum water-equivalent depth data to achieve
the required dose distribution.
The difference between ITV generation with and without
consideration of 4DCT range information is demon-
strated in fig. 5 for a lung tumor patient. Fig. 5a displays
the 4DCT reference phase at end-exhalation with contours
of GTVexhale and ITV, the end-inhalation motion phase is
shown in fig. 5b. If optimization of a treatment plan to the
ITV is based on the reference 4DCT phase only, dose cov-
erage of the distal GTVinhale (stationary target at end-inha-
lation) edge is not sufficient (fig. 5c). Incorporating range
information from all 4DCT phases results in adequate
coverage (fig. 5d).
The additional treatment parameters for gating and res-
canning (gating window and number of rescans) can be
determined or even optimized by performing correspond-
ing dose calculations. Simulated organ motion trajecto-
ries and particle extraction rate are necessary for this step.
By variation of the parameters for organ motion and beam
application coverage of the CTV can be analyzed for differ-
ent gating and rescanning parameters.
Optimization of tracking-parameters
Treatment delivery by tracking
For tracking, target motion is mitigated by adaptation of
the reference treatment plan parameters during treatment
delivery. Calculation of the compensation parameters
∆(x, y, z) is based on a 4DCT data set and corresponding
transformation maps (cf. section Organ motion parame-
ters). Compensation parameters have to be calculated
during treatment planning because calculations are too
time-consuming to be performed online during treatment
delivery. Because motion trajectory and temporal scan-
ning progress (determined by the synchrotron extraction)
are not known at the time of treatment planning, com-
pensation parameters have to be calculated for all possible
interplay combinations. During treatment delivery, the
motion phase is continuously measured, ideally with the
same system as used for 4DCT acquisition. Based on the
currently irradiated grid position the corresponding pre-
calculated compensation parameter set ∆(x, y, z) is used
for beam adaptation. Fluctuations in synchrotron extrac-
tion have no impact on compensation parameter sets
because the intensity controlled raster-scanning process
determines which grid-position is irradiated. The motion
detection system continuously determines the actual
motion phase or interrupts the irradiation if the current
motion state is not included in the pre-calculated param-
eter sets.
Adaptation of the 3D pencil beam position ∆(x, y, z) only
is not sufficient if organ motion includes non-transla-
tional degrees of freedom. In general, irradiation of a spe-
cific grid position results in dose deposition at nearby as
well as more proximal grid positions (see fig. 6a). These
dose contributions are considered during optimization of
ITV optimization Figure 5
ITV optimization. The effect of optimization to an ITV 
incorporating 4DCT information. Reference 4DCT phase at 
end-exhalation (a) and end-inhalation (b) with GTV and ITV 
contours in white. c) If treatment plan optimization to the 
ITV is based on the reference 4DCT phase only, dose cover-
age of GTVinhale can not be guaranteed. d) GTVinhale coverage 
is achieved by including range information of all 4DCT phases 
into the optimization of the ITV based treatment plan. The 
dose distributions in c) and d) are calculated for a stationary 
target and end-inhalation.Radiation Oncology 2007, 2:24 http://www.ro-journal.com/content/2/1/24
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the reference treatment plan. For simple translational
motion, the optimized dose distribution can be achieved
by tracking because beam adaptation compensates trans-
lations and the 3D grid of pencil beam positions is
unchanged. For non-translational degrees of freedom, e.g.
rotations or deformations, the 3D grid position arrange-
ment changes. As a consequence dose contributions from
nearby or more distal grid positions change in compari-
son to the initial reference treatment plan (see fig. 6b). For
particles prone to fragmentation such as C-12, an addi-
tional, similar effect occurs. The so called fragmentation
tails will also be deposited at different positions in com-
parison to the reference, but with smaller doses compared
to the ones deposited in the entrance channel.
Mitigation of dose changes ∆D due to dose contributions
that differ from those in the reference treatment plan can
be achieved by adaptation of the number of particles ∆N
at each 3D grid position. Because the target is scanned
only once in a pre-determined manner, ∆D depends on
the irradiation order of iso-energy slices and the scan path
within each slice. Dose contribution mitigation is only
possible for dose changes resulting from grid positions
irradiated previously. The irradiations should therefore
start with the highest beam energy at the most distal slice
because dose contributions to different grid positions are
significantly higher in the entrance channel than in the
fragment tail.
Calculation of compensation parameters
The number of required beam position compensation
parameters ∆(x, y, z) is determined by the number of grid
positions and the number of motion phases because in
principle each grid position can be irradiated during each
motion phase. The detailed calculation of the compensa-
tion parameter combinations is as follows:
i. Determination of the CT coordinate of each grid posi-
tion in the reference treatment plan by conversion from
the water-equivalent system to the CT system based on the
reference 4DCT phase (fig. 1, grey volume)
ii. Motion vector determination (fig. 1): the transforma-
tion maps (section Organ motion parameters) provide the
geometrical transformation into all other 4DCT phases.
iii. Lateral compensation (∆x,  ∆y): corresponds to the
motion vector components
iv. Longitudinal compensation component ∆z: corre-
sponds to the change in particle range between the origi-
nal grid position in the reference 4DCT phase and the
transformed grid position (fig. 1, white circle in red vol-
ume) in the corresponding 4DCT phase.
To compensate for variations in dose contributions, the
dose change ∆D is determined as part of optimization for
each beam position and each motion phase. Since each
grid position causes specific dose contributions to other
grid-positions and since these contributions depend on
the actual motion phase during irradiation, resulting dose
changes depend on the interplay pattern. Both, under-
and over-dosage in comparison to the reference treatment
plan are possible. The steps to calculate parameters for
dose contribution compensation are as follows:
i. For each grid position of the reference treatment plan
dose contributions to all grid positions irradiated after-
wards are determined on the reference 4DCT phase (see
fig. 7a).
Dose contribution compensation Figure 7
Dose contribution compensation. a) For the reference 
motion phase dose contributions from each grid position (x, 
y, E, N) on grid positions irradiated later (x', y', E', N') are cal-
culated based on lateral distance r and depth z'. b) Changes in 
dose contribution ∆D are computed based on the 4DCT 
phase of interest including the adaptation of Bragg peak posi-
tion ∆(x, y, z) and ∆(x', y', z'). This results in a shift of the 
depth dose distribution d(E, z + ∆z), shift of z' (by ∆z'), as 
well as a change in lateral distance (r').
Impact of non-translational motion components on dose  deposition Figure 6
Impact of non-translational motion components on 
dose deposition. a) Reference dose distribution: Irradiation 
of a beam position (arrow) results in dose deposition along 
the beam path (color gradient). b) For motion including rota-
tions or deformations simple motion compensation by adap-
tation of the Bragg peak position is not sufficient because 
dose deposition in the entrance channel changes.Radiation Oncology 2007, 2:24 http://www.ro-journal.com/content/2/1/24
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ii. The calculation in (i) is repeated for all possible motion
phases. This dose calculation has to consider the changed
4DCT phase as well as the compensation based on the
Bragg peak position, ∆(x, y, z) (fig. 7b).
iii. The change in dose ∆D due to different contributions
is the difference between the dose contributions of (i) and
(ii).
During treatment, changes in deposited dose ∆D are used
to determine the required change in particle deposition
∆N. Each grid position causes dose changes ∆D at several
other grid-positions irradiated afterwards which are taken
from the pre-calculated data depending on the motion
phase valid at the time of delivery. Consequently each grid
position suffers from dose changes from grid-positions
irradiated previously. For determination of ∆N, the cumu-
lative dose changes from all previously irradiated grid
positions is used (∑∆D). The adjustment ∆N is given by
∆N = -ND-1∑∆D where N and D are parameters of the ref-
erence treatment plan. If N + ∆N is negative, i.e. if too
much dose has been applied, no particles are delivered at
the grid position but the over-dosage can not be corrected
for. This shows the lack of optimization for the described
approach, but this is unavoidable if arbitrary motion tra-
jectories of beam and target can occur. The main goal is
avoidance of under-dosage.
Example patient data
The 4DCT data of the lung tumor patient shown in fig. 5
were used to compare different motion mitigation tech-
niques. Apart from ITV generation (fig. 5 and section
Optimization for rescanning, gating) the calculation of
compensation parameters for tracking was necessary. The
4DCT consists of 10 motion phases. The phase corre-
sponding to end-exhalation was used as reference 4DCT
phase. The reference treatment plan for tracking to the
CTV consisted of 7389 grid positions. Thus 73890 beam
position compensation vectors were calculated, each with
two lateral components (∆x, ∆y) in millimeter and a lon-
gitudinal component ∆z in millimeter water-equivalence.
The resulting data are shown in fig. 8. The reference treat-
ment plan was optimized for an anterior-posterior field,
so the y-component of the scanner coordinates (up-down
in beam's eye view) corresponds to cranio-caudal motion,
which was on the order of 12 mm peak-to-peak.
The results from dose calculations for the reference treat-
ment plan on the end-exhalation phase as well as for the
mitigation techniques internal margins, tracking, and gat-
ing are shown in fig. 9. In comparison to the reference
dose distribution (stationary, fig. 9a), tracking (fig. 9c)
and gating (fig. 9d) allow comparable CTV coverage in the
presence of motion. Fig. 9b shows that internal margins
can not be used to mitigate motion influence for a
scanned beam because interplay between target motion
and beam motion prevails.
Discussion
We have implemented 4D treatment planning for charged
particle radiotherapy with scanned pencil beams. Dose
calculations in the presence of motion as well as optimi-
zations for gating, rescanning, and tracking are based on
time-resolved anatomical data, motion trajectories, and
extraction characteristics of the accelerator.
Theoretically, tracking of the target with the scanned pen-
cil beam should result in the best possible sparing of sur-
rounding, healthy tissues. Whereas for gating and
rescanning, required ITV margins lead to an increased PTV
that encompasses surrounding tissues. For gating, the size
of the gating window and the resulting residual target
motion will determine ITV expansions. Then a trade off
between treatment delivery time and target conformity
has to be made. Comparing the motion mitigation tech-
niques, it should be noted that increasing conformity will
elevate technical complexity. As long as tracking has not
been developed for clinical routine use, we clearly favor
gating in comparison to rescanning due to the increase in
conformity. Currently, treatment planning studies based
Motion compensation parameters Figure 8
Motion compensation parameters. For all combinations 
of reference treatment plan grid positions (GridPos, (x, y, E, 
N)) and motion phases (MotPhase #0 – #9) a compensation 
vector ∆(x, y, zwater) is computed. In this example the refer-
ence plan consisted of 7389 grid positions (GridPostotal). For 
10 motion phases, this results in 73890 compensation vec-
tors to describe beam adaptation from the reference motion 
phase (#5) to all other 9 motion phases. Parameters are 
shown for an anterior-posterior field, so the y component in 
the scanning coordinate system (beam's eye view) corre-
sponds to cranio-caudal motion. For this patient, peak-to-
peak tumor motion amplitude was approximately 12 mm.Radiation Oncology 2007, 2:24 http://www.ro-journal.com/content/2/1/24
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on 4DCT patient data are performed to explore and quan-
titatively evaluate the differences between motion mitiga-
tion techniques.
In general, treatment planning – independent whether in
3D or 4D – relies on the validity of the input data. In cur-
rent practice, these data are most often assumed to be
ground truth throughout the treatment course. Genera-
tion of the required input data is out of the scope of this
paper. We will therefore only briefly discuss possible
implications on 4D treatment planning.
4DCT samples moving anatomy in several discrete 3D
motion phases. Usually motion is detected during data
acquisition by an external monitoring system to sort CT
data according to respiratory phases. As pointed out by
several authors, 4DCT is not free of residual motion arti-
facts for example due to irregular respiration
[22,23,25,26,49]. Such artifacts will have an impact on
4D planning, manifested by wrong position of the target
and possible changes in particle ranges. Possible improve-
ments in 4DCT data acquisition are currently under inves-
tigation [50-52].
Target motion trajectories could be measured directly by
fluoroscopy [53,54] or indirectly by external motion
detection systems [28-30]. Techniques and limitations of
motion detection systems are out of the scope of this con-
tribution; we assume a reliable detection of motion
phases. For retrospective dose calculations, motion trajec-
tories have to be recorded during irradiations only. For
optimization of motion mitigation strategies, the treat-
ment delivery system has to react to actual motion phases
online. Fluoroscopic tracking has been successfully used
in Japan [53]. Treatments are gated with millimeter preci-
sion based on trajectories of fiducial markers close to the
target. Currently, fluoroscopic tracking of the target or
nearby structures without fiducial markers is under inves-
tigation. If external motion detection systems have to be
used, ideally, the same motion detection system would be
used during treatment delivery as was used for 4DCT data
acquisition.
Besides target motion beam motion during scanned beam
application has to be considered to model interplay
effects. Recording of the irradiation time of each beam
position has already been implemented at GSI. Treatment
times for individual pencil beam positions are typically
below 10 ms which usually results in less than 0.1 mm of
motion for typical respiratory parameters.
Conclusion
We extended GSI's treatment planning system TRiP to full
4D functionality. The new modules facilitate 4D dose cal-
culation and optimization for tracking, gating, rescan-
ning, and internal margins. Calculations and
optimizations are based on 4DCT information, organ
motion, and trajectory of the scanned ion pencil beam.
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